[Federal Register Volume 86, Number 20 (Tuesday, February 2, 2021)]
[Notices]
[Pages 7859-7860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02136]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Institute of Standards and Technology


Notice of NIST's Consortium for the Advancement of Genome Editing

AGENCY: National Institute of Standards and Technology (NIST), 
Commerce.

ACTION: Notice of Research Consortium; extension of Research 
Consortium.

-----------------------------------------------------------------------

SUMMARY: The National Institute of Standards and Technology (NIST) 
extends the duration of the NIST Consortium for the Advancement of 
Genome Editing (Genome Editing Consortium or Consortium) to December 1, 
2025. NIST will now accept letters of interest to participate in this 
Consortium on an ongoing basis. The Consortium duration was originally 
through December 1, 2020, and the deadline for letters of interest was 
originally January 1, 2020. NIST is taking this action to provide 
additional time for interested parties to join the Consortium and to 
ensure the successful implementation and achievement of outcomes of the 
current Consortium activities, as well as to address additional 
standards needs as defined by the Consortium.

DATES: The Consortium's activities will continue until December 1, 
2025. NIST will accept letters of interest to participate in this 
Consortium on an ongoing basis. Acceptance of participants into the 
Consortium will depend on the availability of NIST resources.

ADDRESSES: Information in response to this notice, including completed 
letters of interest or requests for additional information about the 
Consortium, can be directed via mail to the Consortium Manager, Dr. 
Samantha Maragh, Biosystems and Biomaterials Division of NIST's 
Material Measurement Laboratory, 100 Bureau Drive, Mail Stop 8312, 
Gaithersburg, Maryland 20899, or via electronic mail to 
<a href="/cdn-cgi/l/email-protection#d4a7b5b9b5baa0bcb594babda7a0fab3bba2"><span class="__cf_email__" data-cfemail="becddfd3dfd0cad6dffed0d7cdca90d9d1c8">[email protected]</span></a>, or by telephone at (301) 975-4947.

FOR FURTHER INFORMATION CONTACT: J'aime Maynard, CRADA Administrator, 
National Institute of Standards and Technology's Technology 
Partnerships Office, by mail to 100 Bureau Drive, Mail Stop 2200, 
Gaithersburg, Maryland 20899, by electronic mail to 
<a href="/cdn-cgi/l/email-protection#a4eec5cdc9c18ac9c5ddcac5d6c0e4cacdd7d08ac3cbd2"><span class="__cf_email__" data-cfemail="3278535b5f571c5f534b5c534056725c5b41461c555d44">[email protected]</span></a>, or by telephone at (301) 975-8408.

SUPPLEMENTARY INFORMATION: On January 11, 2018, NIST published a notice 
in the Federal Register (83 FR 1335), about establishing the Genome

[[Page 7860]]

Editing Consortium. The notice requested letters of interest on or 
before January 1, 2020. Multiple parties expressed interest in 
submitting letters of interest and participating in the Consortium 
after the original deadline, and have asked for an extension. In light 
of these requests, NIST extends the term of the Consortium to December 
1, 2025, and will accept letters of interest on an ongoing basis. 
Previously submitted letters of interest do not need to be resubmitted.

(Authority: 15 U.S.C. 3710a)

Kevin A. Kimball,
Chief of Staff.
[FR Doc. 2021-02136 Filed 2-1-21; 8:45 am]
BILLING CODE 3510-13-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>